U.S. Supreme Court: FCA Falsity Shown By ‘Usual And Customary’ Pricing Knowledge
WASHINGTON, D.C. — A unanimous U.S. Supreme Court on June 1 ruled that pharmacies accused of fraudulently overcharging Medicare, Medicaid and the Federal Employee Health Benefits Program for prescription drugs in...To view the full article, register now.
Already a subscriber? Click here to view full article